Table 1 Association between the 21 SNP genotypes and mortality of 43 NSCLC patients receiving gemcitabine, based on the corresponding P value.
From: Novel SNP improves differential survivability and mortality in non-small cell lung cancer patients
No | SNP genotypes | Significance Level (P value) |
|---|---|---|
1 | POLA2+1747 GG/GA | 0.0406 |
2 | RRM1(-756) TT/TC | 0.0896 |
3 | RRM1(-269) CC/CA | 0.0993 |
4 | SLC28A2+65 CC/CT | 0.1794 |
5 | SLC28A2+225 CC/CA | 0.1927 |